12-29443389-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001353179.2(OVCH1):āc.3234A>Cā(p.Glu1078Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001353179.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OVCH1 | NM_001353179.2 | c.3234A>C | p.Glu1078Asp | missense_variant | 25/26 | ENST00000537054.2 | NP_001340108.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OVCH1 | ENST00000537054.2 | c.3234A>C | p.Glu1078Asp | missense_variant | 25/26 | 3 | NM_001353179.2 | ENSP00000445480.2 | ||
OVCH1 | ENST00000318184.9 | c.3129A>C | p.Glu1043Asp | missense_variant | 25/28 | 1 | ENSP00000326708.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459482Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726014
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.3129A>C (p.E1043D) alteration is located in exon 25 (coding exon 25) of the OVCH1 gene. This alteration results from a A to C substitution at nucleotide position 3129, causing the glutamic acid (E) at amino acid position 1043 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at